Commercial Excellence Resources
From product launch to patient engagement and brand strategy to lifecycle planning, improve both experience and outcomes with these expert resources and help from independent commercial excellence consultants.
-
DownloadThe Life Science Leader's Guide to On-Demand Talent
This guide explores eight key capabilities in which high-end independent talent are serving life science companies, from market access and clinical solutions to strategy and transformation...
-
Find the perfect commercial excellence consultant.
Start a Project -
Download
Trends by Industry: Life Science
Life science executives are turning to independent talent for real-world experience and strategic rigor in areas like market access, clinical operations, commercial strategy, and digital health.
-
ReadThe Lasting Impact of COVID-19 on U.S. Pharma Marketing
How can pharma marketers remain effective and relevant for key customers, patients, and healthcare providers (HCPs) in the time of COVID-19?
-
ReadLife Science Lens: On-Demand Talent for Resilience and Agility
On-demand talent is a critical resource for life science and pharma companies as they innovate to keep pace with market changes, respond to emerging health threats, and adapt to a remote environment.
-
ReadOn-Demand Talent for Innovation, Transformation, and Growth in Life Sciences
Independent talent provide an agile source of critical skills that allow life science leaders to keep pace in a fast-changing environment.
-
How are independent talent helping companies blaze paths to renewed growth?
See 2021 Trends -
ReadA Rare Disease Specialist Fluent in the Project Location’s Language
In an effort to inform its Rare Diseases commercial strategy within a specific country, an F100 pharmaceutical company was looking to gain a deeper understanding of the current competitive...
-
ReadNavigating a New Reality: Commercial Strategy and COVID-19
Commercial strategy leaders must prepare now to ensure success for potential COVID-19 treatments. Biopharma expert Marc Cooley shares what life science companies should keep in mind at this moment.
-
See our commercial excellence capabilities and talent bios.
Read More -
ReadNavigating a New Reality: Pharmaceutical Detailing in a Digital World
COVID-19 is sidelining the field reps that life science companies rely on for in-person pharmaceutical detailing. Healthcare marketing strategist Martine Taylor discusses how eDetailing can help.
-
ReadPharma Product Launch Best Practices
Independent biopharma marketer Kimberly Crichton explains how technology is changing the way life science companies launch products and communicate with consumers and healthcare providers.
-
ReadAccelerating Pharma Product Launch: A Q&A With Ron Niesen
Life Science project leader Ron Niesen discusses pharma product launch best practices, from gathering data to streamlining decisions.
-
ReadBiopharma Product Launch
A global biopharmaceutical company was preparing to launch a promising new rare disease therapy in the UK and Europe. Concerned that the company’s functional leads were too busy managing existing...
-
ReadBuilding Commercial Centers of Excellence: A Q&A With David Davidovic
Independent commercial operations expert David Davidovic talks about assessing new technologies, making fast decisions, and building commercial centers of excellence.
-
How can independent talent help you?
Let's Talk -
ReadEarly-Stage Marketing Support
A major pharmaceutical company was pursuing multiple indications for a groundbreaking oncology therapy. Struggling to keep up with the work, the global marketing team concluded it would need to...
-
DownloadBTG Key Strengths: Commercial Strategy and Operations in Life Sciences
Get results-driven consultants and project managers for your marketing, sales, operations and analytics initiatives.
-
ReadPatient Centric Marketing: 4 Practical Steps
These days, you'd be hard-pressed to find a life science company that doesn't strive for patient centricity. But what does patient-centric marketing mean?
-
ReadWhat Does Payer/Provider Consolidation Mean For the Future of Pharma?
The lines are blurring between U.S. healthcare payers and providers. What does this payer/provider consolidation mean for pharma? Nothing less than a total shift in the way it does business. If...
-
ReadCommercializing A Breakthrough Medicine
A major biopharmaceutical company had developed a breakthrough medication that stood to dramatically disrupt the market for its therapeutic area. Expected to be approved by the FDA in the next...
-
DownloadDigitizing Life Sciences: The Revolution Is Here (Again)
By now, the story is familiar: new techniques in AI and data analysis are revolutionizing business decisions and driving productivity, innovation, and efficiency across the enterprise.
-
ReadPatient Engagement Strategies That Work for Life Science
If you work in Life Science, you’re probably familiar with the sobering statistics on nonadherence: between 20% and 30% of medication prescriptions are never filled, and roughly 50% of chronic...
-
ReadRevamping the Payer Strategy
The head of strategy at a health services company had ambitious plans for growth, but needed to mitigate risk by re-examining his payer strategy. Unfortunately, his internal team was...
-
Loading More...
